View Older Stories
-
Tenon Medical closes $4.3 million convertible notes private placement
-
Tenon Medical Announces Closing of Private Placement of Senior Convertible Notes Offering for Gross Proceeds of $ 4.3 Million
-
Tenon Medical receives patent allowances from USPTO
-
Tenon(R) Medical Strengthens Intellectual Property Portfolio with Strategic Patent Expansion
-
Tenon Medical, Inc. Sets Date for Fourth Quarter and Full Year 2025 Earnings, Reaffirms Expected Revenues
-
Tenon Medical reports Q4 revenue growth of 90% year-over-year
-
Tenon(R) Medical Issues Shareholder Letter and Provides Preliminary Revenue for the Fourth Quarter and Full Year 2025
-
Tenon Medical (TNON) files for 5.43M share offering by selling stockholders
-
Tenon Medical Announces Successful Completion of Initial Cases with New SImmetry(R)+ SI Joint Fusion System
-
Tenon Medical closes $2.85 million PIPE financing
-
Tenon Medical Announces Closing of $2.85 Million At-The-Market PIPE Financing
-
Tenon Medical (TNON) Misses Q3 EPS by 2c
-
Tenon(R) Medical Reports Third Quarter 2025 Financial Results
-
Tenon Medical prices $2.85 million PIPE financing at $1.285 per share
-
Tenon Medical(R) Announces Pricing of At-The-Market PIPE Financing
-
Tenon Medical, Inc. Announces Timing of Third Quarter 2025 Financial Results
-
Tenon Medical receives FDA clearance for SImmetry+ SI joint fusion system
-
Tenon Medical(R) Announces FDA 510(k) Clearance for SImmetry(R)+ SI Joint Fusion System
-
Tenon Medical reports 12-month study results for SI joint fusion device
-
Tenon(R) Medical Announces Second Peer-Reviewed Catamaran Mainsail(TM) Study Publication, Underscores Robust and Sustainable Clinical Outcomes Out to 12 Months
-
Tenon Medical launches Catamaran SE SI joint fusion system
-
Tenon(R) Medical Announces the Full Market Launch of the Catamaran(R) SE SI Joint Fusion System
-
Tenon Medical (TNON) Misses Q2 EPS by 36c
-
Tenon Medical Reports Second Quarter 2025 Financial Results
-
Tenon Medical, Inc. Announces Timing of Second Quarter 2025 Financial Results
-
Tenon Medical(R) Expands Sacro-Pelvic Fusion Portfolio with Strategic Asset Acquisition
-
Tenon Medical Announces Initial Case Series Utilizing Catamaran(R) SI Joint Fusion System to Enhance Stabilization of the SI Joint for Patients Undergoing Lumbar Fusion
-
Tenon Medical (TNON) Misses Q1 EPS by 101c
-
Tenon Medical, Inc. Announces Timing of First Quarter 2025 Financial Results
-
Tenon Medical (TNON) Files for 5.67M Share Offering by Selling Stockholders
-
Tenon Medical, Inc. Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
-
Tenon Medical (TNON) Announces a Registered Direct Offering and Concurrent Private Placement
-
Tenon Medical, Inc. Announces a Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
-
Tenon Medical (TNON) Announces FDA Clearance of Catamaran SI Joint Fusion System for New Indication to Augment Spinal Fusion
-
Tenon Medical(R) Announces FDA Clearance of Catamaran(R) SI Joint Fusion System for New Indication to Augment Spinal Fusion
-
Tenon Medical Reports Fourth Quarter and Full Year 2024 Financial Results
-
Tenon Medical, Inc. Announces a Warrant Inducement Transaction for $3.0 Million in Gross Proceeds
-
Tenon Medical (TNON) Receives Approval for Notice of Allowance from the European Patent Office
-
Tenon Medical(R) Receives Approval for Notice of Allowance from the European Patent Office
-
Tenon Medical, Inc. Announces Timing of Fourth Quarter and Full Year 2024 Financial Results
-
Tenon Medical(R) to Host Meetings During the 2025 J.P. Morgan Healthcare Conference in San Francisco
-
Tenon Medical Reports Third Quarter 2024 Financial Results
-
Tenon Medical Announces Initial Clinical Cases Successfully Completed with Company’s New Catamaran(R) SE SI Joint Fusion System
-
Tenon Medical, Inc. Announces Timing of Third Quarter 2024 Financial Results
-
Tenon Medical (TNON) Regains Nasdaq Compliance
-
Tenon Medical(R) Regains Full Compliance with Nasdaq Continued Listing Requirements
-
Tenon Medical (TNON) Announces Issuance of Three U.S. Patents
-
Tenon Medical(R) Announces Issuance of Three U.S. Patents
-
Tenon Medical (TNON) Issues Three Notices of Allowance for Patent Applications from the USPTO
-
Tenon Medical Announces Issuance of Three Notices of Allowance for Patent Applications from the USPTO

